Literature DB >> 7142090

Comparative pharmacokinetics of cefadroxil, cefaclor, cephalexin and cephradine in infants and children.

C M Ginsburg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7142090     DOI: 10.1093/jac/10.suppl_b.27

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  The effect of four different types of food on the bioavailability of cefaclor.

Authors:  S Karim; T Ahmed; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jul-Sep       Impact factor: 2.441

2.  Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.

Authors:  N C James; K H Donn; J J Collins; I M Davis; T L Lloyd; R W Hart; J R Powell
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

3.  Third generation cephalosporins in the parenteral to oral switch.

Authors:  D Rimmer
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

4.  The pharmacokinetics of cefixime in the fasted and fed state.

Authors:  R D Faulkner; W Bohaychuk; J D Haynes; R E Desjardins; A Yacobi; B M Silber
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis.

Authors:  M E Pichichero; F A Disney; G H Aronovitz; W B Talpey; J L Green; A B Francis
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

6.  Comparison of cefadroxil and cephalexin in the treatment of community-acquired pneumonia.

Authors:  M J Blaser; B D Klaus; J A Jacobson; E Kasworm; F M LaForce
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

7.  Oral cephalosporins for use in a parenteral-to-oral switch programme.

Authors:  D M Rimmer
Journal:  Infection       Date:  1995       Impact factor: 3.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.